Lilly unloads long-time research operations in Greenfield: Buyer Covance plans to keep all 260 local employees
But the Indianapolis-based drugmaker hopes Indiana sees no net loss of jobs from its restructuring moves. The Aug. 6 announcement is part of a quickening effort by Lilly to reduce overhead costs before it loses patent protection on a string of drugs, which now make up 60 percent of its revenue. In Greenfield, Lilly is selling its labs for toxicology and other drug development tests to New Jersey-based Covance Inc., a contract research organization. Covance is paying Lilly $50 million…